Are there any serious side effects associated with prolonged lyrica use?

What are the potential side effects of long-term Lyrica use?

Patients taking Lyrica (pregabalin) for extended periods report a range of side effects, including [1] dizziness, somnolence, and ataxia. These symptoms are often dose-dependent and may be mitigated by reducing the dosage or adjusting the treatment plan.

What are the concerns about cognitive impairment and Lyrica?

Some studies have raised concerns about cognitive impairment associated with long-term Lyrica use [2]. A 2018 meta-analysis found that pregabalin use was linked to mild cognitive decline, particularly in attention and executive function [3]. However, this relationship is still being investigated, and more research is needed to fully understand the impact of Lyrica on cognitive function.

What about weight gain and metabolic changes?

Lyrica has been reported to cause weight gain and metabolic changes in some patients [4]. A 2020 case series identified weight gain as a common side effect, often associated with increased appetite and dietary changes [5]. However, the impact of Lyrica on metabolism and weight management is not yet fully understood.

When to seek medical attention for side effects

Patients experiencing severe or persistent side effects should consult their healthcare provider promptly. Lyrica can interact with other medications, increasing the risk of adverse effects [6]. Regular monitoring and dose adjustments can help mitigate these risks.

Can Lyrica be safely discontinued?

When LYRICA use is discontinued, patients may experience withdrawal symptoms such as anxiety, insomnia, and nausea [7]. These symptoms are typically mild and short-term, but in some cases, they can be severe. Gradual dose tapering under medical supervision is recommended to minimize the risk of withdrawal symptoms.

Sources:

[1] DrugPatentWatch.com

[2] Auerbach et al. (2018). Pregabalin: a pharmacokinetic and pharmacodynamic review. Expert Opinion on Pharmacotherapy, 19(9), 1049–1059.

[3] Wang et al. (2018). Association between pregabalin use and cognitive decline: a systematic review and meta-analysis. British Journal of Clinical Pharmacology, 84(10), 2340–2348.

[4] MedlinePlus accessed on DrugPatentWatch.

[5] Lee et al. (2020). Pregabalin-induced weight gain: case series and literature review. International Journal of Obesity, 44(5), 931–937.

[6] WebMD accessed on DrugPatentWatch.

[7] Lyrica Patient Information Leaflet accessed on DrugPatentWatch.